GE Healthcare Life Sciences to open biopharma technology lab in Turkey

Published: 14-Nov-2014
Research & Development Pharmaceutical

Laboratory a key component of GE’s new Innovation Centre in Istanbul and supports Turkey’s ambitions to expand domestic biopharmaceutical industry


GE Healthcare Life Sciences, a global tools, technologies and services provider in life science research and biopharmaceutical manufacturing, is to open a Technology and Training Laboratory to support Turkey’s expanding biopharmaceutical and biotechnology industry.

A key component of GE’s Turkey Innovation Centre in Istanbul, the laboratory will open to customers, industry and academic partners from mid-2015. This adds to GE’s global network of biopharmaceutical customer training and technology facilities in the US, UK, China, India and Sweden.

The GE Healthcare Life Sciences Technology Laboratory will feature the company’s latest tools and technologies for drug discovery, protein science and bioprocessing research. It will offer advanced technical training and technology evaluation to the Turkish biopharma sector, as well as being open to universities as a location for elements of biotechnology degree courses. Academics, pharmaceutical and biotechnology researchers will also have access to the laboratory for small scale research studies using the latest GE equipment, as will GE customers from the Middle East and Russia.

Turkey plans to expedite the transformation of its healthcare sector through domestic manufacturing of both devices and pharmaceuticals, with plans for local pharmaceutical manufacturing to represent 60% of the country’s consumption.

'The GE Healthcare Life Sciences Istanbul Technology and Training Laboratory is an excellent commitment to Turkey’s biotechnology goals, and will be very useful to Turkish R&D and industry,' said Dr Irem Yenice, Biotechnology Division Manager, Arven. 'Connecting different scientific fields and helping to strengthen industrial applications, the laboratory could be an important support to growth and innovation in Turkey.'

Myra Eskes, General Manager, GE Healthcare Life Sciences Eastern & Africa Growth Markets said: 'Our investment in the Istanbul Technology and Training Laboratory underscores GE’s commitment to supporting growth in life sciences and the biopharmaceutical industry in both Turkey and the region, complementing and strengthening academic and industry investments in biopharmaceutical research and manufacturing.'

  • Companies:
  • GE Group
See more

You may also like

Manufacturing

Chime Biologics announces $190m funds to accelerate capacity expansion

Read more
The China-based CDMO has plans to increase the total manufacturing capacity to more than 140,000 L within the next 5 years

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year The award recognises employers that create an outstanding experience for employees
  3. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
  4. Rapid increase in purchasing teams expected at CPHI North America Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
  5. Wacker Chemical Corporation promotes Christoph Kowitz to President of US subsidiary The position originally held by David Willhoit is a promotion from Christoph's six year tenure as the Head of Corporate R&D

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Chime Biologics announces $190m funds to accelerate capacity expansion

The China-based CDMO has plans to increase the total manufacturing capacity to more than 140,000 L within the next 5 years
Ingredients

GE Healthcare collaborates to develop ligands for AAV purification

Australian Children’s Medical Research Institute and GE have agreed to develop new affinity ligands for the purification of adeno-associated viral (AAV) vectors used in gene therapies
Manufacturing

GE Healthcare Life Sciences launches software for cell therapy workflow

The SpinOculation C-Pro Protocol software closes and automates the cell transduction step
Research & Development

New Harvard consortium focuses on advanced bioproduction

The overarching mission of the collaboration is to catalyse the development of transformative therapies by shortening the path between research and clinical application
Ingredients

Research partnership removes bottleneck from AAV development

CPI, Cobra Biologics and GE Healthcare Life Sciences have developed a scalable, cost-effective purification process for adeno-associated viruses
Design & Build

GE Healthcare and Germfree working on modular bioprocessing solution

The project is a rapidly deployable process-ready cleanroom and bioprocessing platforms for biotherapeutics such as gene therapy
Manufacturing

GE Healthcare launches automation software for cell therapy

Software has been designed to fit specific requirements to incorporate the platform into existing software and hardware framework
Subscribe now